Form 4 holding
10%+ Owner
PMV Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 127,099
- Estimated value
- $283,431
- Report date
- 14 Jun 2021
- Price
- $2.23
- Ownership
- Indirect
Euclidean Capital LLC
Insider Reports History
- Location
- New York, NY
- Reporting signature
- /s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
SEC record
SEC evidence
Holdings reported by Euclidean Capital LLC:
Insider Reports Filed by Euclidean Capital LLC
4
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 11 Jun 2021
- Transactions
- 10
- Transaction value
- -$2,257,955
- Filing time
- 15 Jun 2021, 18:58
- Role
- 10%+ Owner
- Next action
- Open filing details
4
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 09 Jun 2021
- Transactions
- 10
- Transaction value
- -$2,007,709
- Filing time
- 11 Jun 2021, 17:35
- Role
- 10%+ Owner
- Next action
- Open filing details
4
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 07 Jun 2021
- Transactions
- 10
- Transaction value
- -$2,091,787
- Filing time
- 09 Jun 2021, 18:17
- Role
- 10%+ Owner
- Next action
- Open filing details
3
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 28 Apr 2021
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 07 May 2021, 16:51
- Role
- 10%+ Owner
- Next action
- Open filing details